logo
logo
Sign in

Lupus Market Executive Summary, by Types and Treatment, Regional Overview 2027

avatar
Market Media Hub
Lupus Market Executive Summary, by Types and Treatment, Regional Overview 2027

Market Research Future (MRFR) analysed the Global Lupus Market 2020 for the forecast period till 2023. As per MRFR analysis, the lupus market can rise at 11.2% CAGR in the study period. By 2023, the lupus market value can exceed USD 1.48 Bn.

The increases in cases of systemic autoimmune disease, such as lupus, is creating significant demand for robust treatments. Major regulatory bodies and medical institutions are raising funds, backed by government, to provide effective medical solutions to inflammation throughout the body (characteristics of lupus). These can support the expansion of the lupus market through the review period. Skin, kidney, joints, blood vessels, heart, lungs, and brain are organs that are affected in lupus. Lupus patients are highly prone to COVID 19, thus boost in their treatment regimen is observed that can contribute to the market expansion. Increase in prevalence of lupus, rigorous research and development activities, and ongoing medical advancements for systemic lupus treatment can bolster the expansion of the market in the years to come.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6636 

Competitive Analysis

The global lupus market holds a number of noteworthy players, including Merck KGaA, Cadila Healthcare, Mylan N.V., F. Hoffmann-La Roche AG, Aurinia Pharmaceuticals, Inc., GlaxoSmithKline PLC, Eli Lily and Company, Pfizer, Inc., Bristol-Myers Squibb Company, Lycera Corporation, and Sanofi.

Dec 11th, 2018, Neovacs, a pioneer in the field of active immune therapy for treating autoimmune diseases, announced the continuation of its partnership with Centurion Pharma in Lupus (SLE). This is based on the study results of the Phase IIb trial with IFNalpha Kinoid.

Segmentation Analysis

The global market for lupus has been segmented into types, treatment, and end-user.

  • On the basis of type, the global lupus market has been segmented into cutaneous lupus erythematosus, systemic lupus erythematosus, neonatal lupus, cutaneous lupus erythematosus, and drug-induced lupus erythematosus. The segment for systemic lupus erythematosus is anticipated to hold the largest market share due to its growing prevalence and rising drug development in recent years.
  • On the basis of treatment, the global lupus market has been segmented into immunosuppressants, nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, corticosteroids, biologics, and other.
  • On the basis of the end-user, the global lupus market has been segmented into hospitals & clinics, diagnostic laboratories, and others.

Regional Analysis

Region-wise, the global lupus market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas are anticipated to dominate the global market for lupus due to the growing demand for improved treatment options, increasing prevalence of lupus, government programs for lupus, and availability of reimbursement. In addition, the development of the healthcare infrastructure and the accessibility of biologics are projected to promote the growth of the market in the region.

Europe is set to retain the second-largest position in the global market for lupus. Market growth in this region is driven by the increasing number of research and development activities and the growing prevalence of lupus in the region.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/lupus-market-6636 

The Asia Pacific region is anticipated to be the fastest-growing region due to the increasing prevalence of lupus, the continuous growth of the healthcare sector, and the rising regional expansion of prominent market players. As reported by the Australian Society of Clinical Immunology and Allergy, more than 20,000 people in Australia and New Zealand were affected by lupus in 2016.

The Middle East and Africa has the lowest market share. The majority of the market in this area is projected to be held by the Middle East region owing to a well-developed healthcare sector and increasing government initiatives in the healthcare sector.    

collect
0
avatar
Market Media Hub
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more